Stephen Hoffman Net Worth & Insider Trades
Stephen Hoffman - Chief Executive Officer, Aerpio Pharmaceuticals, Inc
What is Stephen Hoffman's Net Worth?
The current estimated net worth of Aerpio Pharmaceuticals, Inc's Chief Executive Officer, Stephen Hoffman, is estimated to be about $26.1M . Stephen Hoffman owns about 31,967 units of Aerpio Pharmaceuticals, Inc common stock. In the last 2 years at Aerpio Pharmaceuticals, Inc, Stephen Hoffman has sold an estimated value of $0 worth.
What is Stephen Hoffman's Past Insider Trading?
Stephen Hoffman's largest purchase order was 31,967 units , worth over $64.14K on November 14, 2018. In total, Stephen Hoffman has made about 5 transactions over 2 years of their time at Aerpio Pharmaceuticals, Inc. Stephen Hoffman usually trades in April, May, November, December and February, with the busiest year in 2018 and 2019.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
STEPHEN HOFFMAN
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Stephen Hoffman's' Mailing Address?
- Mailing address is C/o Skyline Ventures 525 University Ave., Suite 1350 Palo Alto CA 94301 CA
Aerpio Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Option Awards
|
Bonus
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Joseph Gardner | 2020 | $432,600 | $48,427 | $210,000 | $108,150 | $1,646 | $590,823 |
| Joseph Gardner | 2019 | $420,000 | $510,423 | - | $199,500 | $1,069 | $1,130,992 |
| Regina Marek | 2020 | $278,100 | $29,057 | $120,000 | $48,668 | $350 | $356,175 |
| Regina Marek | 2019 | $244,643 | $168,866 | - | $71,708 | $373 | $485,590 |
| Kevin Peters | 2020 | $370,800 | $40,304 | $180,000 | $74,160 | $1,003 | $486,267 |
| Kevin Peters | 2019 | $360,000 | $450,200 | - | $136,800 | $1,069 | $948,069 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1422142/000156459021032185/arpo-def14a_20210722.htm
What are Aerpio Pharmaceuticals, Inc's Past Insider Trades?
Aerpio Pharmaceuticals, Inc's most recent insider trade came on December 10, 2020 by Orbimed Advisors Llc and Orbimed Capital GP V Llc who sold 21,400 units worth $41.94K . In the last 2 years, insiders at Aerpio Pharmaceuticals, Inc have sold an estimated value of $1.84M and bought an estimated value of $14.39M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Muneer Satter, Director, Ag Novartis, and Novartis Bioventures Ltd .
Aerpio Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||